Triiodothyronine + baicalein
Triiodothyronine + baicalein has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, May 26, 2025: “Bidirectional upregulation of Klotho by triiodothyronine and baicalein: mitigating chronic kidney disease and associated complications in aged BALB/c mice”.
See all 1 papers on triiodothyronine + baicalein
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Anusandhan National Research Foundation and 3 more
- Animals1
What did studies of triiodothyronine + baicalein find?
5Studies of triiodothyronine + baicalein measured 5 outcomes, among them dyslipidemia, cardiovascular disease and renal fibrosis.
Dyslipidemia
downin mice1
1 study
Dyslipidemia
downin mice1
Triiodothyronine + baicalein decreases dyslipidemia in mice (combined treatment in adenine-induced CKD mice).
“mitigating renal fibrosis and CKD complications, including cardiovascular disorders and dyslipidemia”
Animalscombined treatment in adenine-induced CKD mice
Biogerontology
Cardiovascular disease
downin mice1
1 study
Cardiovascular disease
downin mice1
Triiodothyronine + baicalein decreases cardiovascular disease in mice (combined treatment in adenine-induced CKD mice).
“mitigating renal fibrosis and CKD complications, including cardiovascular disorders and dyslipidemia”
Animalscombined treatment in adenine-induced CKD mice
Biogerontology
Renal fibrosis
downin mice1
1 study
Renal fibrosis
downin mice1
Triiodothyronine + baicalein decreases renal fibrosis in mice (combined treatment in adenine-induced CKD mice).
“mitigating renal fibrosis and CKD complications, including cardiovascular disorders and dyslipidemia”
Animalscombined treatment in adenine-induced CKD micekidney
Biogerontology
TGF, NFκB and GSK3 signaling
downin mice1
1 study
TGF, NFκB and GSK3 signaling
downin mice1
Triiodothyronine + baicalein decreases TGF, NFκB and GSK3 signaling in mice (combined treatment in adenine-induced CKD mice).
“suppressed key signaling molecules (TGF, NFκB, GSK3)”
Animalscombined treatment in adenine-induced CKD mice
Biogerontology
Klotho
upin mice1
1 study
Klotho
upin mice1
Triiodothyronine + baicalein increases Klotho in mice (combined treatment in adenine-induced CKD mice) (surpassing individual effects of each agent).
“Combined T3 and BAI treatment significantly increased Klotho levels, surpassing individual effects”
Animalscombined treatment in adenine-induced CKD mice
Biogerontology